unpreced
pandem
infect
one
millon
peopl
declar
intern
public
health
emerg
eosinopenia
may
predict
poor
prognosi
howev
date
detail
analysi
clinic
characterist
patient
eosinopenia
describ
clincial
characterist
patient
eosinopenia
phenotyp
median
age
patient
year
old
male
patient
sever
type
higher
proport
dyspnea
gastrointestin
symptom
compar
mild
moder
patient
laboratori
find
indic
lower
count
lymphocyt
eosnophil
observ
patient
sever
type
cough
sputum
fatigu
common
symptom
eosinopenia
patient
compar
noneosinopenia
patient
high
proport
comorbid
observ
eosinopenia
patient
laboratori
find
indic
lymphocyt
count
median
eosinopenia
patient
significantli
less
noneosinopenia
patient
median
p
use
corticosteroid
therapi
patient
medrxiv
preprint
eosinopenia
notabl
higher
patient
noneosinopenia
vs
respect
compar
paramet
noneosinopenia
patient
eosinopenia
patient
inclin
less
lymphocyt
count
valu
eosinopenia
common
patient
particularli
sever
patient
common
symptom
includ
fever
cough
sputum
fatigu
frequent
eosinopenia
patient
eosinopenia
may
repres
novel
phenotyp
need
investig
sinc
decemb
seri
resembl
viral
pneumonia
case
unknown
caus
occur
wuhan
china
clinic
present
inclu
fever
cough
myalgia
fatigu
dyspnoea
sputum
product
headach
haemoptysi
diarrhoea
resembl
viral
pneumonia
similar
sever
respiratori
ill
caus
sever
acut
respiratori
syndrom
coronaviru
becom
global
unpreced
pandem
infect
one
millon
peopl
declar
intern
public
health
emerg
overal
rate
sever
case
mortal
nationwid
analysi
china
elderli
peopl
complic
comorbid
impair
immun
function
involv
multipl
lung
lobe
risk
factor
patient
sever
critic
diseas
earli
stage
increas
serum
ddimer
predict
poor
prognosi
pf
patient
meanwhil
lower
count
cell
high
cardiac
troponin
two
predictor
high
mortal
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
dysregul
immun
respons
featur
decreas
immun
cell
count
elev
inflammatori
cytokin
mount
evid
shown
lymphopenia
common
patient
close
relat
sever
note
du
colleagu
found
fatal
case
low
count
blood
eosinophil
admisson
eosinopenia
predict
poor
prognosi
normal
blood
eosinophil
treatment
may
indic
improv
howev
date
lack
detail
analysi
patient
eosinopenia
aim
studi
describ
clinic
characterist
patient
eosinopenia
phenotyp
order
improv
knowledg
multicent
retrospect
studi
conduct
three
tertiari
hospit
yijishan
hosptial
wanan
medic
colleg
second
peopl
hospit
wuhu
citi
first
peopl
hospit
hefei
citi
patient
review
januari
march
studi
approv
ethic
committe
yijishan
hosptial
wanan
medic
second
peopl
hospit
wuhu
citi
first
peopl
hospit
hefei
citi
inform
consent
patient
waiv
sinc
studi
follow
polici
publichealthoutbreak
investig
emerg
infecti
diseas
issu
nation
health
commiss
peopl
republ
china
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
data
analysi
multicent
retrospect
studi
total
patient
review
januari
march
patient
mild
moder
sever
median
age
patient
year
old
male
patient
sever
type
significantli
older
patient
mild
moder
type
median
age
vs
vs
year
old
patient
sever
type
higher
proport
dyspnea
gastrointestin
symptom
patient
mild
moder
type
p
tabl
common
symptom
includ
cough
sputum
fatigu
myalgia
reach
statist
differ
among
type
fifteen
patient
one
comorbid
mostli
patient
sever
type
tabl
laboratori
find
indic
increas
ddimer
median
concentr
crp
median
concentr
mgdl
observ
patient
sever
type
compar
mild
moder
type
median
concentr
ngml
ngml
p
mgdl
mgdl
respect
lower
count
lymphocyt
median
count
cell
l
eosnophil
median
count
observ
patient
sever
type
though
statist
differ
among
type
tabl
patient
receiv
ct
scan
radiolog
featur
lung
show
patient
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
nineteen
patient
treat
corticosteroid
admisson
use
corticosteroid
therapi
highest
sever
patient
mild
moder
patient
tabl
patient
receiv
antivir
treatment
includ
inhal
recombin
interferon
lopinavirritonavir
arbidol
oseltamivir
one
sever
patient
receiv
convalesc
plasma
therapi
tocilizumab
tabl
radiograph
improv
time
longer
patient
sever
type
moder
type
median
day
vs
respect
statist
differ
observ
viroloy
improv
time
hospit
stay
among
mild
sever
type
tabl
median
age
patient
eosinopenia
significantli
higher
patient
noneosinopenia
vs
respect
eosinopenia
patient
higher
temperatur
noneosinopenia
patient
median
highest
temperatur
vs
cough
sputum
fatigu
common
symptom
eosinopenia
patient
compar
noneosinopenia
patient
vs
vs
vs
respect
high
proport
comorbid
observ
eosinopenia
patient
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
laboratori
find
indic
lymphocyt
count
median
eosinopenia
patient
significantli
less
noneosinopenia
patient
median
p
ast
concentr
median
valu
ul
eosinopenia
patient
higher
noneosinopenia
patient
median
valu
ul
laboratori
paramet
well
radiolog
featur
lung
reach
statist
differ
two
group
tabl
admiss
use
corticosteroid
therapi
patient
eosinopenia
notabl
higher
patient
noneosinopenia
vs
respect
radiograph
improv
time
median
day
hospit
stay
median
day
patient
eosinopenia
numer
longer
patient
noneosinopenia
median
day
respect
tabl
howev
statist
differ
two
group
patient
receiv
inhal
recombin
interferon
twentyeight
eosinopenia
patient
treat
lopinavirritonavir
arbidol
oseltamivir
convalesc
plasma
therapi
tocilizumab
use
one
sever
patient
eosinopenia
tabl
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
studi
patient
sever
type
cure
count
eosnophil
well
lymphocyt
dramat
elev
normal
recoveri
patient
sever
type
compar
adimiss
count
white
blood
cell
differ
group
figur
becom
emerg
rapidli
evolv
public
health
emerg
worldwid
unbias
sequenc
sampl
patient
novel
viru
name
previous
name
confirm
seventh
meber
coronavirus
famili
recent
metaanalysi
data
patient
indic
fever
cough
myalgia
fatigu
expector
dyspnea
main
clinic
symptom
symptom
includ
headach
diarrhea
nausea
vomit
minor
remark
lymphopenia
frequent
patient
tao
chen
colleagu
report
higher
proport
lymphopenia
deceas
patient
recov
patient
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
implic
lymphopenia
might
predictor
poor
outcom
present
studi
report
clinic
characterist
patient
outsid
hubei
provinc
first
describ
clinic
featur
novel
type
eosinopenia
phenotyp
hope
result
studi
deep
knowledg
futur
work
adequ
evalu
sever
crucial
import
mount
evid
indic
eldli
patient
inclin
develop
sever
condit
higher
rate
dyspnea
lymphopenia
crp
ddimer
sever
patient
moder
patient
consist
previou
studi
found
median
age
patient
sever
type
significantli
older
patient
mild
moder
type
sever
patient
higher
proport
dyspnea
gastrointestin
symptom
patient
mild
moder
type
meanwhil
result
studi
indic
proport
cough
sputum
fatigu
myalgia
numer
high
sever
patient
chest
ct
play
vital
role
differenti
diagnosi
li
x
etal
report
around
patient
two
lobe
involv
imag
multipl
lesion
local
peripher
bilater
lung
studi
patient
receiv
chest
ct
scan
radiolog
featur
lung
show
patient
sever
patient
bilater
pneumonia
found
onethird
patient
treat
corticosteroid
highest
sever
patient
patient
receiv
antivir
treatment
one
sever
patient
receiv
convalesc
plasma
therapi
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
tocilizumab
statist
differ
observ
hospit
stay
among
patient
studi
may
due
lack
adequ
knowledg
unpreced
pandem
present
studi
lymphopenia
increas
ddimer
crp
common
sever
patient
may
primarili
infect
lymphocyt
result
lymphopenia
well
decreas
product
lymphopenia
elev
crp
may
use
predictor
develop
pneumonia
acut
respiratori
distress
syndrom
ard
patient
dysfunct
blood
coagul
sever
patient
paid
concern
preval
venou
thromboembol
vte
patient
around
ddimer
promis
biomark
identifi
highrisk
group
vte
note
studi
half
patient
develop
eosinopenia
particularli
sever
patient
similar
result
report
previou
studi
eosinopenia
may
indic
poor
prognosi
patient
autopsi
deceas
reveal
minim
eosinophil
eosinophil
lung
tissu
howev
pathogenesi
eosinopenia
remain
determin
may
relat
deplet
cell
produc
stimul
eosinophil
prolifer
eosinophil
consumpt
caus
higher
viral
load
eosinophil
play
import
role
parasit
infect
produc
antivir
molecul
respiratori
virus
includ
respiratori
syncyti
viru
influenza
howev
role
eosinophil
infect
larg
unknown
studi
patient
eosinopenia
older
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
corticosteroid
therapi
still
controversi
manag
earli
corticosteroid
therapi
close
associ
high
blood
sarscov
load
delay
merscov
clearanc
therefor
corticosteroid
therepi
avoid
patient
unless
indic
moder
sever
ard
septic
shock
short
durat
low
dose
corticosteroid
therapi
may
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
limit
studi
first
despit
multicent
retrospect
studi
anhui
provinc
china
sampl
studi
still
small
may
lead
unavoid
bia
second
clinic
signific
eosinopenia
need
investig
final
studi
observ
studi
experiment
research
perform
reveal
pathogenesi
eosinopenia
eosinopenia
common
patient
particularli
sever
patient
may
indic
poor
prognosi
patient
common
symptom
includ
fever
cough
sputum
fatigu
frequent
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
design
studi
collect
analysi
interpret
data
support
anhui
provinci
key
project
natur
scienc
foundat
colleg
univers
key
project
scienc
technolog
prevet
control
wuhu
citi
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ast
aspart
aminotransferas
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ast
aspart
aminotransferas
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
